Evidence map›Paper›PMID 41764739›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

Dual T cell receptor expression provides intrinsic advantage for agonist selection of thymic FoxP3+ regulatory T cells (Tregs) in the neonatal thymus.

Hyun J Jang, Burhan Jama, Elizabeth A Mills, Preston A Humphries, Nimi Marcel, Li-Fan Lu, Wan-Lin Lo, Gerald P Morris

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyun J JangDepartment of Pathology, University of California, San Diego, La Jolla, CA, United States.
Burhan JamaDepartment of Pathology, University of California, San Diego, La Jolla, CA, United States.
Elizabeth A MillsDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Preston A HumphriesDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Nimi MarcelDepartment of Molecular Biology, University of California, San Diego, La Jolla, CA, United States.
Li-Fan LuDepartment of Molecular Biology, University of California, San Diego, La Jolla, CA, United States.
Wan-Lin LoDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, United States.
Gerald P MorrisDepartment of Pathology, University of California, San Diego, La Jolla, CA, United States.ORCID 0000-0002-1097-4453

Funding

DEVELOPMENTAL BIOLOGY TRAINING PROGRAMT32HD007491 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI James Alan Gagnon, Kristen M Kwan · 1995 to 2026
$8.0M
Role of microRNAs in regulatory T cell-mediated immunological tolerance and T celR01AI108651 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LU, LI-FAN · 2014 to 2024
$4.0M
Study the Treg-IL-27 axis in immune regulationR01AI188710 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHU, HIUTUNG, LU, LI-FAN · 2025 to 2025
$3.0M
Unmasking the Immunomodulatory Roles of CD7 SignalingR01AI175301 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Wan-Lin Lo · 2023 to 2026
$2.2M
Dual TCR Expression Effects on Alloreactivity and TransplantationR01AI151293 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MORRIS, GERALD PATRICK · 2020 to 2024
$1.9M
NIAID NIH HHS R01 AI108651NIAID NIH HHS R01 AI151293NIAID NIH HHS R01 AI175301NIAID NIH HHS R01 AI188710NICHD NIH HHS T32 HD007491NIH HHS R01AI108651NIH HHS R01AI151293NIH HHS R01AI175301NIH HHS R01AI188710NIH HHS T32HD007491
6 · The paper itself

Abstract

Co-expression of 2 T cell receptor (TCR) clonotypes due to allelic inclusion occurs in ∼16% of peripheral blood T cells in mice and humans. Evidence indicates dual TCR expression can affect thymic development and peripheral function. Notably, dual TCR cells demonstrate increased reactivity against self-antigens and heightened TCR signaling, properties that could favor development of FoxP3+ regulatory CD4+ T cells (Tregs). However, the impact of dual TCR expression on Treg development remains controversial. We hypothesize that this discrepancy arises from 2 opposing factors: While dual TCR expression enhances TCR signal strength and promotes agonist selection into the Treg lineage, the capacity of the thymic Treg niche may impose extrinsic limitations that obscure this effect. To test this hypothesis, we utilized the B6.TCRA-GFP/RFP reporter model, which enables precise identification of single and dual TCRα-expressing cells. We found that dual TCR expression is associated with increased frequencies of thymic Tregs in neonatal (day 10) mice, an age characterized by robust Treg output, but not in adults. In both age groups, dual TCR Tregs exhibited elevated expression of Nur77, consistent with stronger TCR signaling during selection. However, in adult mice, the presence of recirculating peripheral Tregs reduces niche availability, thereby diminishing the selection advantage conferred by dual TCR expression. These findings reveal a previously underappreciated role for dual TCR expression in shaping thymic Treg development and provide insight into mechanisms of self-tolerance in neonates and in settings such as hematopoietic stem cell transplantation.

Indexed as

Receptors, Antigen, T-CellThymus GlandT-Lymphocytes, RegulatoryAnimalsAnimals, NewbornCell DifferentiationForkhead Transcription FactorsMiceMice, Inbred C57BLMice, TransgenicNuclear Receptor Subfamily 4, Group A, Member 1Signal TransductionForkhead Transcription FactorsFoxp3 protein, mouseNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1Receptors, Antigen, T-CellT cellT cell receptorTCRTreg

Identifiers

PMID41764739
PMCPMC13378001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.